title: Aripiprazole augmentation for treatment-resistant bipolar depression: sustained remission after 36 months.
authors.forename: David E
authors.initials: DE
authors.lastname: Kemp
authors.forename: Pedro L
authors.initials: PL
authors.lastname: Dago
authors.forename: Joshua L
authors.initials: JL
authors.lastname: Straus
authors.forename: Jenelle
authors.initials: J
authors.lastname: Fleck
authors.forename: Melissa
authors.initials: M
authors.lastname: Karaffa
authors.forename: William S
authors.initials: WS
authors.lastname: Gilmer
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D000068180:Aripiprazole; D001714:Bipolar Disorder / Q000188:drug therapy*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D011446:Prospective Studies; D015363:Quinolones / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole